Does SECUKINUMAB Cause Sars-cov-2 test positive? 378 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 378 reports of Sars-cov-2 test positive have been filed in association with SECUKINUMAB (COSENTYX). This represents 0.3% of all adverse event reports for SECUKINUMAB.
378
Reports of Sars-cov-2 test positive with SECUKINUMAB
0.3%
of all SECUKINUMAB reports
6
Deaths
64
Hospitalizations
How Dangerous Is Sars-cov-2 test positive From SECUKINUMAB?
Of the 378 reports, 6 (1.6%) resulted in death, 64 (16.9%) required hospitalization, and 3 (0.8%) were considered life-threatening.
Is Sars-cov-2 test positive Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SECUKINUMAB. However, 378 reports have been filed with the FAERS database.
What Other Side Effects Does SECUKINUMAB Cause?
Drug ineffective (27,434)
Psoriasis (21,976)
Pain (15,244)
Arthralgia (13,769)
Fatigue (9,406)
Psoriatic arthropathy (8,900)
Pruritus (8,755)
Malaise (8,570)
Rash (8,023)
Condition aggravated (7,536)
What Other Drugs Cause Sars-cov-2 test positive?
OCRELIZUMAB (1,421)
ADALIMUMAB (1,301)
DUPILUMAB (860)
NIRMATRELVIR\RITONAVIR (538)
LENALIDOMIDE (469)
CERTOLIZUMAB PEGOL (361)
RISANKIZUMAB-RZAA (335)
RITUXIMAB (305)
UPADACITINIB (281)
INFLIXIMAB (269)
Which SECUKINUMAB Alternatives Have Lower Sars-cov-2 test positive Risk?
SECUKINUMAB vs SELADELPAR LYSINE
SECUKINUMAB vs SELEGILINE
SECUKINUMAB vs SELENIUM
SECUKINUMAB vs SELENIUM SULFIDE
SECUKINUMAB vs SELEXIPAG